NCT06879717
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06879717
Title A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients (PULMO-01)
Acronym PULMO-01
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors iOnctura
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | ESP | BEL

Facility Status City State Zip Country Details
Antwerp University Hospital Antwerp 2650 Belgium Details
AZ Delta VZW Roeselare 8800 Belgium Details
Istituto Romagnolo per lo studio dei Tumori "Dino Amadori" Meldola Forlì-Cesena 47014 Italy Details
Humanitas University, Department of Medical Oncology Rozzano Milan 20072 Italy Details
Institut Català d'Oncologia Hospitalet Barcelona 08908 Spain Details
Hospital Universitari Son Espases Palma 07120 Spain Details
Hospital Universitario y Politécnico La Fe Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field